Skip to main content
Download PDF

The effects of antihypertensive drugs on arterial stiffness

Artery Research volume 14, pages 1–5 (2016)Cite this article

Abstract

Ageing and cardiovascular risk factors, particularly uncontrolled hypertension, adversely impact arterial stiffness and wave reflection leading to increased central systolic blood pressure. Carotid-femoral pulse wave velocity is the “gold standard” method for the assessment of aortic stiffness. Increased pulse wave velocity has been independently associated with adverse cardiovascular outcomes. Thus, current European hypertension guidelines acknowledge the reproducibility, predictive value, and cost-effectiveness of pulse wave velocity.

Augmentation index, a marker of arterial stiffness and wave reflection has been also associated with poor cardiovascular outcome.

Current evidence suggests that increased arterial stiffness and wave reflection contribute to target organ damage. Thus, early intervention is fundamental for cardiovascular prevention. Elevated pulse wave velocity and augmentation index can be reduced by normalizing blood pressure and by using specific treatments for reducing arterial stiffness.

This article will review the available evidence on the effect of the different antihypertensive drug classes on arterial stiffness. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers can reduce pulse wave velocity beyond the blood pressure lowering effect. Although blood pressure normalization is the most effective therapeutic tool for reducing parameters of wave reflections, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers have beneficial effects on augmentation index.

References

  1. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588–605.

    Google Scholar 

  2. Nilsson PM, Boutouyrie P, Cunha P, Kotsis V, Narkiewicz K, Parati G, et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens 2013;31:1517–26.

    Google Scholar 

  3. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009;54:3–10.

    Google Scholar 

  4. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318–27.

    Google Scholar 

  5. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014;63:636–46.

    Google Scholar 

  6. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Eur Heart J 2007;28:1462–536.

    Google Scholar 

  7. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 2013;31:1281–357.

    Google Scholar 

  8. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010;31: 1865–71.

    Google Scholar 

  9. Chirinos JA, Kips JG, Jacobs Jr DR, Brumback L, Duprez DA, Kronmal R. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (multiethnic study of atherosclerosis). J Am Coll Cardiol 2012;60:2170–7.

    Google Scholar 

  10. Ait-Oufella H, Collin C, Bozec E, Laloux B, Ong KT, Dufouil C, et al. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens 2010;28: 2336–41.

    Google Scholar 

  11. Ghiadoni L, Bruno RM, Stea F, Virdis A, Taddei S. Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essentialhypertension. Curr Hypertens Rep 2009; 11:190–6.

    Google Scholar 

  12. Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S, et al. Pharmacological modulation of arterial stiffness. Drugs 2011;71:1689–701.

    Google Scholar 

  13. Koumaras C, Tzimou M, Stavrinou E, Griva T, Gossios TD, Katsiki N, et al. Role of antihypertensive drugs in arterial ‘destiffening’ and central pulsatile hemodynamics. Am J Cardiovasc Drugs 2012;12:143–56.

    Google Scholar 

  14. Schiffrin EL. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension 2012;59:367–74.

    Google Scholar 

  15. Probstfield JL, O’Brien KD. Progression of cardiovascular damage: the role of renin-angiotensin system blockade. Am J Cardiol 2010;105:10A–20A.

    Google Scholar 

  16. Ghiadoni L, Taddei S, Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol 2012; 10:42–60.

    Google Scholar 

  17. Agabiti-Rosei E, Rizzoni D. Regression of small resistance artery structural alterations in hypertension by appropriate antihypertensive treatment. Curr Hypertens Rep 2010;12:80–5.

    Google Scholar 

  18. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003;41: 1281–6.

    Google Scholar 

  19. Ong KT, Delerme S, Pannier B, Safar ME, Benetos A, Laurent S, et al. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens 2011;29:1034–42.

    Google Scholar 

  20. Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 2012;221:18–33.

    Google Scholar 

  21. Tropeano AI, Boutouyrie P, Pannier B, Joannides R, Balkestein E, Katsahian S, et al. Brachial pressure-independent reduction in carotid stiffness after long-termcangiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006;48:80–6.

    Google Scholar 

  22. Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townsend JN. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol 2009;54:505–12.

    Google Scholar 

  23. Asmar RG, London GM, O’Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001;38:922–6.

    Google Scholar 

  24. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001;104:1464–70.

    Google Scholar 

  25. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation 2006;113:1213–25.

    Google Scholar 

  26. Greig LD, Leslie SJ, Gibb FW, Tan S, Newby DE, Webb DJ. Comparative effects of glyceryl trinitrate and amyl nitrite on pulse wave reflection and augmentation index. Br J Clin Pharmacol 2005;59:265–70.

    Google Scholar 

  27. O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46:200–4.

    Google Scholar 

  28. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009;54: 1328–36.

    Google Scholar 

  29. Laurent S, Briet M, Boutouyrie P. Arterial stiffness as surrogate end point: needed clinical trials. Hypertension 2012;60: 518–22.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126, Via Pisa, Italy

    Lorenzo Ghiadoni

Authors
  1. Lorenzo Ghiadoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorenzo Ghiadoni.

Additional information

This article was presented as lecture in the symposium on “Arterial stiffness: a translational approach” at the ARTERY 14 Congress in Maastricht, The Netherlands (October 9–11, 2014).

Rights and permissions

This is an open access article distributed under the CC BY-NC license. https://doi.org/creativecommons.org/licenses/by/4.0/

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghiadoni, L. The effects of antihypertensive drugs on arterial stiffness. Artery Res 14, 1–5 (2016). https://doi.org/10.1016/j.artres.2016.02.001

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.artres.2016.02.001

Keywords

Artery Research

ISSN: 1876-4401

Contact us